| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 0.44× | 0.44× | 3.42× | 5.45× | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.01× | 0.01× | 0.01× | 0.01× | 0.01× | ||
| 0.64× | 0.64× | 0.66× | 0.61× | 0.91× | ||
| 0.79× | 0.79× | 0.77× | 0.67× | 0.94× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | — | 5.45 | 3.42 | 0.44 | 0.44 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Cash Conversion (CFO/Net Income) | 0.91 | 0.61 | 0.66 | 0.64 | 0.64 | |
| CFO/EBITDA | 0.94 | 0.67 | 0.77 | 0.79 | 0.79 |